Coronary Heart Disease Diagnostic Imaging Devices Market To Reach $7.73 Billion By 2033

Coronary Heart Disease Diagnostic Imaging Devices Market Growth & Trends

The global coronary heart disease diagnostic imaging devices market size is expected to reach USD 7.73 billion by 2033, registering a CAGR of 6.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increase in coronary diseases and deaths associated with it calls for better and early diagnosis of the condition. Precise scan interpretation and technologically advanced equipment are the factors influencing the market growth. Various imaging modalities are useful in identifying unique aspects of coronary screening. For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries. However, non-invasive techniques like single-photon computed tomography (SPECT) and positron emission tomography (PET) provide indirect information on CHD by estimating the myocardial perfusion and metabolism abnormalities that are consequent of coronary artery disease.

Technological advancement in this field had led to the development of sharp camera units consisting of gamma systems, that use semiconductor detectors of cadmium zinc telluride (CZT). This led to faster acquisition of images, reduced capture time, high image quality, and lower radiation dose (1mSv for a single injection), as compared to conventional myocardial perfusion imaging by SPECT. Further, improvements around Computed Tomography, to develop non-invasive techniques have also shown great future growth in this segment. However, economic barriers, subject literacy, and lack of medical staff hold back the implementation of such advanced techniques in real practice.

The coronary heart disease diagnostic imaging devices market saw a sharp decline in 2020, due to the outbreak of the COVID-19 pandemic. Fear of virus spread, the shift in focus on diagnosing and treating COVID-19 affected patients, reduced admission rates at hospitals for other diseases, and reduced medical staff, led to the reduction in the diagnosis of CVD. Economic setback observed by end-users also influenced the adoption of advanced techniques to effectively diagnoses coronary alterations. Further, the shutting down of manufacturing units, due to national lockdowns, halt in logistics, and reduction in salesforce also impacted the market negatively.

 Request a free sample copy or view report summary: Coronary Heart Disease Diagnostic Imaging Devices Market Report

Coronary Heart Disease Diagnostic Imaging Devices Market Report Highlights

• The growing participation of people in recreational and competitive boating activities worldwide is estimated to provide an upthrust to the growth. Besides, advancements in technologies leading to the introduction and adoption of connected boats are projected to fuel growth over the forecast period.

• The growing awareness among customers regarding the benefits offered by integrating technologies in conventional boats is expected to fuel market growth over the forecast period.

• Recreational boating activities are gaining popularity among tourists owing to the increasing number of boating events and trade shows hosted in different parts of the world

• The used Coronary Heart Disease Diagnostic Imaging Devices segment held the largest share of 75.88% in 2025. This trend is attributed to the fact that used boats can be acquired relatively quickly, thereby reducing delivery times.

• The new Coronary Heart Disease Diagnostic Imaging Devices segment is expected to grow at a significant CAGR during the forecast period. The new Coronary Heart Disease Diagnostic Imaging Devices segment is expected to grow significantly over the forecast period.

• The motorized segment held the largest market share in 2025. Boating is one of many outdoor recreational pursuits that are popular worldwide. The demand for motorized leisure vessels is rising as more people look for ways to interact with nature and spend their free time in an active and adventurous way

• North America Coronary Heart Disease Diagnostic Imaging Devices market accounted for a 43.56% share of the overall market in 2025. The North America Coronary Heart Disease Diagnostic Imaging Devices market held a dominant position in 2025.

Coronary Heart Disease Diagnostic Imaging Devices Market Segmentation

Grand View Research has segmented the global coronary heart disease diagnostic imaging devices market report based on type, product, and region:

Coronary Heart Disease Diagnostic Imaging Devices Modality Outlook (Revenue, USD Million, 2021 - 2033)

• Computed Tomography

• X rays

• Ultrasound

• Magnetic Resonance Imaging

• Nuclear Medicine

Coronary Heart Disease Diagnostic Imaging Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Coronary Heart Disease Diagnostic Imaging Devices Market

• GE Healthcare

• Koninklijke Philips

• Siemens Healthineers AG

• Fujifilm Sonosite, Inc.

• Canon Medical Systems Corporation

• Samsung Medison Co. Ltd

• Shimadzu Corporation

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd

• Arineta Ltd

• Esaote SpA